Acura Pharmaceuticals Return on Investment 2012-2021 | ACUR
Current and historical return on investment (ROI) values for Acura Pharmaceuticals (ACUR) over the last 10 years.
| Acura Pharmaceuticals ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2021-12-31 | $0.00B | $0.00B | 80.00% |
| 2021-09-30 | $0.00B | $0.00B | 36.36% |
| 2021-06-30 | $0.00B | $0.00B | 36.36% |
| 2021-03-31 | $0.00B | $0.00B | 23.53% |
| 2020-12-31 | $0.00B | $0.00B | 36.36% |
| 2020-09-30 | $0.00B | $0.00B | 100.00% |
| 2020-06-30 | $0.00B | $0.00B | 0.00% |
| 2020-03-31 | $0.00B | $0.00B | -133.33% |
| 2019-12-31 | $0.00B | $0.00B | -266.67% |
| 2019-09-30 | $0.00B | $0.00B | -266.67% |
| 2019-06-30 | $0.00B | 0 | 0.00% |
| 2019-03-31 | $0.00B | $0.00B | 600.00% |
| 2018-12-31 | $0.00B | $0.00B | 600.00% |
| 2018-09-30 | $-0.01B | $0.00B | 666.67% |
| 2018-06-30 | $-0.01B | 0 | -2400.00% |
| 2018-03-31 | $-0.01B | $0.00B | -933.33% |
| 2017-12-31 | $-0.01B | $0.00B | -285.71% |
| 2017-09-30 | $0.00B | $0.00B | -36.36% |
| 2017-06-30 | $0.00B | $0.00B | -33.33% |
| 2017-03-31 | $0.00B | $0.00B | -47.06% |
| 2016-12-31 | $-0.01B | $0.01B | -104.35% |
| 2016-09-30 | $-0.01B | $0.01B | -112.50% |
| 2016-06-30 | $-0.01B | $0.01B | -81.82% |
| 2016-03-31 | $-0.01B | $0.01B | -65.31% |
| 2015-12-31 | $0.00B | $0.01B | -22.64% |
| 2015-09-30 | $0.00B | $0.01B | -30.19% |
| 2015-06-30 | $-0.01B | $0.01B | -37.04% |
| 2015-03-31 | $-0.01B | $0.02B | -38.71% |
| 2014-12-31 | $-0.01B | $0.02B | -67.61% |
| 2014-09-30 | $-0.01B | $0.02B | -60.47% |
| 2014-06-30 | $-0.01B | $0.02B | -74.29% |
| 2014-03-31 | $-0.01B | $0.01B | -101.96% |
| 2013-12-31 | $-0.01B | $0.01B | -185.71% |
| 2013-09-30 | $-0.01B | 0 | 0.00% |
| 2013-06-30 | $-0.01B | 0 | 0.00% |
| 2013-03-31 | $-0.01B | 0 | 0.00% |
| 2012-12-31 | $-0.01B | 0 | 0.00% |
| 2012-09-30 | $-0.01B | 0 | 0.00% |
| 2012-06-30 | $-0.01B | 0 | 0.00% |
| 2012-03-31 | $0.01B | 0 | 0.00% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2011-09-30 | $0.01B | 0 | 0.00% |
| 2011-06-30 | $0.01B | 0 | 0.00% |
| 2011-03-31 | $-0.01B | 0 | 0.00% |
| 2010-12-31 | $-0.01B | 0 | 0.00% |
| 2010-09-30 | $-0.01B | 0 | 0.00% |
| 2010-06-30 | $-0.02B | 0 | 0.00% |
| 2010-03-31 | $-0.02B | 0 | 0.00% |
| 2009-12-31 | $-0.01B | 0 | 0.00% |
| 2009-09-30 | $-0.01B | 0 | 0.00% |
| 2009-06-30 | $-0.01B | 0 | 0.00% |
| 2009-03-31 | $0.01B | 0 | 0.00% |
| 2008-12-31 | $0.02B | 0 | 0.00% |
| 2008-09-30 | $0.01B | 0 | 0.00% |
| 2008-06-30 | $0.01B | $0.00B | 400.00% |
| 2008-03-31 | $0.00B | $0.00B | 28.57% |
| 2007-12-31 | $-0.02B | $0.00B | -428.57% |
| 2007-09-30 | $-0.01B | $-0.01B | 166.67% |
| 2007-06-30 | $-0.01B | $-0.01B | 91.67% |
| 2007-03-31 | $-0.01B | $-0.01B | 78.57% |
| 2006-12-31 | $-0.01B | $-0.02B | 75.86% |
| 2006-09-30 | $-0.02B | $-0.01B | 304.76% |
| 2006-06-30 | $-0.01B | $0.00B | 509.09% |
| 2006-03-31 | $-0.01B | $0.00B | 2600.00% |
| 2005-12-31 | $-0.01B | $0.00B | -1466.67% |
| 2005-09-30 | $0.04B | $0.00B | 1800.00% |
| 2005-06-30 | $-0.02B | $0.00B | -461.54% |
| 2005-03-31 | $-0.03B | $0.00B | -2400.00% |
| 2004-12-31 | $-0.04B | $0.00B | -4100.00% |
| 2004-09-30 | $-0.07B | 0 | -28000.00% |
| 2004-06-30 | $-0.03B | $-0.01B | 260.47% |
| 2004-03-31 | $-0.02B | $-0.01B | 270.97% |
| 2003-12-31 | $-0.02B | $-0.01B | 272.00% |
| 2003-09-30 | $-0.02B | $0.00B | 685.71% |
| 2003-06-30 | $-0.02B | $0.01B | -336.00% |
| 2003-03-31 | $-0.02B | $0.01B | -360.00% |
| 2002-12-31 | $-0.01B | $0.00B | -433.33% |
| 2002-09-30 | $-0.02B | $0.00B | 4400.00% |
| 2002-06-30 | $-0.02B | -0 | 6400.00% |
| 2002-03-31 | $-0.01B | -0 | 5600.00% |
| 2001-12-31 | $-0.01B | $0.00B | -720.00% |
| 2001-09-30 | $-0.01B | $0.00B | -400.00% |
| 2001-06-30 | $-0.01B | $0.00B | -285.71% |
| 2001-03-31 | $0.00B | $0.01B | -76.19% |
| 2000-12-31 | $-0.01B | $0.00B | -290.91% |
| 2000-09-30 | $-0.01B | $0.00B | -400.00% |
| 2000-06-30 | $-0.01B | $0.00B | -500.00% |
| 2000-03-31 | $-0.02B | $0.00B | -857.14% |
| 1999-12-31 | $-0.01B | $0.00B | -800.00% |
| 1999-09-30 | $-0.01B | $0.00B | -960.00% |
| 1999-06-30 | $-0.01B | $0.00B | -1466.67% |
| 1999-03-31 | $-0.01B | $0.00B | -880.00% |
| 1998-12-31 | $-0.01B | $0.00B | -320.00% |
| 1998-09-30 | $-0.01B | $0.01B | -155.56% |
| 1998-06-30 | $0.00B | $0.00B | -85.71% |
| 1998-03-31 | $0.00B | $0.00B | -200.00% |
| 1997-12-31 | $0.00B | 0 | 0.00% |
| 1997-09-30 | $-0.01B | $0.00B | 533.33% |
| 1997-06-30 | $-0.02B | $0.00B | 1200.00% |
| 1997-03-31 | $-0.02B | $0.00B | 960.00% |
| 1996-12-31 | $-0.02B | $0.00B | 977.78% |
| 1996-09-30 | $-0.01B | $0.00B | 1800.00% |
| 1996-06-30 | $-0.01B | $0.00B | -280.00% |
| 1996-03-31 | $0.00B | $0.01B | -88.89% |
| 1995-12-31 | $0.00B | $0.01B | -50.00% |
| 1995-09-30 | $-0.02B | $0.01B | -368.00% |
| 1995-06-30 | $-0.01B | $0.00B | -373.33% |
| 1995-03-31 | $-0.01B | $0.00B | -444.44% |
| 1994-12-31 | $0.00B | $0.00B | -228.57% |
| 1994-09-30 | $0.01B | $0.00B | 1040.00% |
| 1994-06-30 | $0.02B | $0.00B | 500.00% |
| 1994-03-31 | $0.02B | $0.01B | 262.07% |
| 1993-12-31 | $0.01B | $0.01B | 143.59% |
| 1993-09-30 | $0.02B | $0.01B | 158.49% |
| 1993-06-30 | $0.02B | $0.01B | 133.33% |
| 1993-03-31 | $0.02B | $0.02B | 117.24% |
| 1992-12-31 | $0.02B | $0.01B | 119.30% |
| 1992-06-30 | $0.00B | $0.01B | 24.00% |
| 1992-03-31 | $0.00B | $0.01B | 26.09% |
| 1991-09-30 | $0.00B | $0.01B | 39.02% |
| 1991-06-30 | $0.00B | $0.01B | 53.33% |
| 1991-03-31 | $0.00B | $0.01B | 80.00% |
| 1990-12-31 | $0.00B | $0.00B | 120.00% |
| 1990-09-30 | $0.00B | 0 | 0.00% |
| 1990-06-30 | $0.00B | 0 | 0.00% |
| 1990-03-31 | $0.00B | 0 | 0.00% |
| 1989-12-31 | $0.00B | 0 | 0.00% |
| 1989-09-30 | $0.00B | 0 | 0.00% |
| 1989-06-30 | $0.00B | 0 | 0.00% |
| 1989-03-31 | $0.00B | 0 | 0.00% |
| 1988-12-31 | $0.00B | 0 | 0.00% |
| 1988-09-30 | $0.00B | 0 | 0.00% |
| 1988-06-30 | $0.00B | 0 | 0.00% |
| 1988-03-31 | $0.00B | 0 | 0.00% |
| 1987-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |